Projects per year
Personal profile
Personal profile
Dr. Wenhao Chen earned his Ph.D. in Biomedical Science from the University of Toronto in 2006. He held faculty appointments at the University of Toledo College of Medicine in Toledo, Ohio and Baylor College of Medicine in Houston, Texas before becoming a member of Houston Methodist Research Institute in 2013. As a member of the Transplantation Immunology Program, Dr. Chen studies the cellular and molecular mechanisms underlying immune tolerance. He has published more than 40 original papers and review articles in high-impact scientific journals.
Research interests
Dr. Chen’s research interests are to define the molecular mechanisms by which immune cells reject the transplanted organs or cause autoimmune type 1 diabetes and develop novel strategies to selectively abrogate undesired immune responses against self-islets or transplanted organs.
Education/Academic qualification
Immunology, Postdoctoral Associate, Baylor College of Medicine
Transplantation Immunology, Postdoctoral Fellowship, University of Texas Health Science Center at Houston
Immunology, Postdoctoral Fellowship, University of Toronto
Biomedical Science, PhD, University of Toronto
Research Area Keywords
- Transplantation
Free-text keywords
- Transplantation
- Type 1 diabetes
- T cell
- Immune tolerance
Fingerprint
Dive into the research topics where Wenhao Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of Irreversible T Cell Dysfunction on Transplant Outcomes
Chen, W. (PI)
1/12/24 → 12/31/24
Project: Federal Funding Agencies
-
Evaluating IRF4 in Kidney Transplant Allograft Biopsies A Single Center, Prospective Study Evaluating IRF4 in kidney transplant allograft biopsies
Yi, S. (PI), Chen, W. (Key Personnel), Gaber, A. O. (Key Personnel), Knight, R. J. (Key Personnel) & Moore, L. W. (Key Personnel)
Project: Clinical Trial
-
Defining Immunology Frailty as a Predictor of Human Liver Allograft Recipient Futility
Chen, W. (Key Personnel), Eagar, T. N. (Key Personnel), Ghobrial, R. M. (Key Personnel), Graviss, E. A. (Key Personnel), Gupte, A. A. (Key Personnel), Hamilton, D. J. (Key Personnel) & Li, X. C. (Key Personnel)
4/10/19 → 8/31/19
Project: Federal Funding Agencies
-
IRF4-dependent T-cell effector programs in governing transplant outcomes
Chen, W. (PI) & Li, X. C. (Key Personnel)
5/1/18 → 1/11/24
Project: Federal Funding Agencies
-
Identification of the intracellular regulators involved in establishing T-cell tolerance to cardiac allografts
Chen, W. (PI) & Li, X. C. (CoI)
9/9/13 → 6/30/15
Project: Non Profit
-
Aerobic glycolysis enables the effector differentiation potential of stem-like CD4+ T cells to combat cancer
Zou, D., Zhang, X., Li, S., Xiao, X., Gonzalez, N. M., Minze, L. J., Li, X. C. & Chen, W., May 2024, In: Cellular and Molecular Immunology. 21, 5, p. 527-529 3 p.Research output: Contribution to journal › Letter › peer-review
-
CD4+ T cell immunity is dependent on an intrinsic stem-like program
Zou, D., Yin, Z., Yi, S. G., Wang, G., Guo, Y., Xiao, X., Li, S., Zhang, X., Gonzalez, N. M., Minze, L. J., Wang, L., Wong, S. T. C., Osama Gaber, A., Ghobrial, R. M., Li, X. C. & Chen, W., Jan 2024, In: Nature immunology. 25, 1, p. 66-76 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Stem the tide of graft rejection
Chen, W. & Li, X. C., Mar 2024, In: American Journal of Transplantation. 24, 3, p. 316-317 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion
Cui, J., Xu, H., Yu, J., Ran, S., Zhang, X., Li, Y., Chen, Z., Niu, Y., Wang, S., Ye, W., Chen, W., Wu, J. & Xia, J., Apr 2024, In: Science Immunology. 9, 94Research output: Contribution to journal › Article › peer-review
-
Continuous Expression of Interferon Regulatory Factor 4 Sustains CD8+ T Cell Immunity against Tumor
Yu, A., Fu, J., Yin, Z., Yan, H., Xiao, X., Zou, D., Zhang, X., Zu, X., Li, X. C. & Chen, W., Nov 2023, In: Research. 6, 0271.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations